BAP1 and intrahepatic cholangiocarcinoma: ICC demonstrated alterations in IDH1 or IDH2 (30%), CDKN2A (40%), FGFR2 (20%), PBRM1 (20%), ARID1A (10%), and BAP1 (10%).